Albert David balance sheet

As of Mar 2026

Total assets: ₹519cr+1.5% on Mar 2025
Shareholders' equity: ₹392cr−0.2% on Mar 2025
Total debt: ₹28.5cr+183.4% on Mar 2025
Cash and investments: ₹225cr−7.1% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	99.1	97.7	81.6	77.6
	20.8	1.7	6.7	2.7
	0.6	1.1	1.8	2.5
	0.0	0.2	0.1	0.0
	18.2	18.0	0.0	0.0
	3.4	0.6	18.8	25.9
	2.7	38.1	15.0	5.8
	6.1	38.7	33.8	31.7
	—	—	—	1.0
	—	—	2.4	4.6
	145	157	126	120
	58.3	63.9	43.6	50.7
	225	242	254	167
	33.9	27.4	29.3	30.3
	0.3	0.4	5.4	1.4
	32.5	1.3	25.7	23.8
	2.0	4.1	4.1	9.1
	4.1	4.6	4.3	15.9
	298	280	323	247
	15.9	8.4	4.9	4.9
	374	354	372	303
	519	511	498	423
Equity
	5.7	5.7	5.7	5.7
	386	387	377	306
	392	392	383	312
	392	392	383	312
Liabilities
	0.0	0.0	0.0	0.6
	0.5	2.6	2.0	2.0
	0.5	2.6	2.0	2.6
	6.6	5.9	10.7	10.2
	5.1	6.3	3.3	0.0
	12.2	14.8	16.0	12.9
	28.5	10.0	2.1	4.7
	32.5	37.6	33.9	32.1
	32.3	32.9	36.7	39.2
	93.3	80.5	72.8	76.0
	18.2	20.6	19.5	19.6
	—	0.0	1.1	0.0
	3.9	3.0	5.7	3.4
	115	104	99.0	98.9
	128	119	115	112
	519	511	498	423
Assets — additional as-filed lines
	2.4	1.7	0.0	0.4
Trade payables — MSME split
	2.1	3.4	—	—
	30.4	34.1	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

ALBERTDAVD₹772.00

Albert David Limited

· Pharma & Health

₹ CrorePeersVALIANTLAB HALEOSLABS ZIMLAB MEDICO MEDICAMEQ ANUHPHR AHCL WANBURYMcap ₹441 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	77.6	81.6	97.7	99.1	99.1
+ Capital Work-in-Progress	2.7	6.7	1.7	20.8	20.8
+ Other Intangibles	2.5	1.8	1.1	0.6	0.6
+ Intangibles under Development	0.0	0.1	0.2	0.0	0.0
+ Investments (Equity Method)	0.0	0.0	18.0	18.2	18.2
+ Non-current Investments	25.9	18.8	0.6	3.4	3.4
+ Other Non-current Financial Assets	5.8	15.0	38.1	2.7	2.7
Non-current Financial Assets	31.7	33.8	38.7	6.1	6.1
+ Deferred Tax Assets	1.0	—	—	—	—
+ Other Non-current Assets	4.6	2.4	—	—	—
Total Non-current Assets	120.0	126.4	157.4	144.7	144.7
Current Assets
+ Inventories	50.7	43.6	63.9	58.3	58.3
+ Current Investments	166.8	254.3	242.2	225.1	225.1
+ Trade Receivables	30.3	29.3	27.4	33.9	33.9
+ Cash & Cash Equivalents	1.4	5.4	0.4	0.3	0.3
+ Other Bank Balances	23.8	25.7	1.3	32.5	32.5
+ Short-term Loans	9.1	4.1	4.1	2.0	2.0
+ Other Current Financial Assets	15.9	4.3	4.6	4.1	4.1
Current Financial Assets	247.4	323.1	280.0	297.9	297.9
+ Other Current Assets	4.9	4.9	8.4	15.9	15.9
Total Current Assets	303.4	371.6	354.0	374.4	374.4
Total Assets	423.4	498.0	511.4	519.1	519.1
Equity
+ Equity Share Capital	5.7	5.7	5.7	5.7	5.7
+ Other Equity / Reserves	305.9	377.3	386.8	385.8	385.8
Equity — Owners of Parent	311.6	383.0	392.5	391.5	391.5
Total Equity	311.6	383.0	392.5	391.5	391.5
Liabilities
+ Borrowings — Non-current	0.6	0.0	0.0	0.0	0.0
+ Other Non-current Financial Liab	2.0	2.0	2.6	0.5	0.5
Non-current Financial Liabilities	2.6	2.0	2.6	0.5	0.5
+ Provisions — Non-current	10.2	10.7	5.9	6.6	6.6
+ Deferred Tax Liabilities	0.0	3.3	6.3	5.1	5.1
Non-current Liabilities	12.9	16.0	14.8	12.2	12.2
+ Borrowings — Current	4.7	2.1	10.0	28.5	28.5
+ Trade Payables	32.1	33.9	37.6	32.5	32.5
+ Other Current Financial Liab	39.2	36.7	32.9	32.3	32.3
Current Financial Liabilities	76.0	72.8	80.5	93.3	93.3
+ Provisions — Current	19.6	19.5	20.6	18.2	18.2
+ Current Tax Liabilities	0.0	1.1	0.0	—	—
+ Other Current Liabilities	3.4	5.7	3.0	3.9	3.9
Current Liabilities	98.9	99.0	104.2	115.4	115.4
Total Liabilities	111.8	115.0	118.9	127.6	127.6
Total Equity & Liabilities	423.4	498.0	511.4	519.1	519.1
Assets — additional as-filed lines
+ Current Tax Assets	0.4	0.0	1.7	2.4	2.4
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	3.4	2.1	2.1
+ Dues to Other Creditors — Current	—	—	34.1	30.4	30.4

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.